» Articles » PMID: 14535558

Preoperative and Postoperative Voice in Tis-T1 Glottic Cancer Treated by Endoscopic Cordectomy: an Additional Issue for Patient Counseling

Overview
Date 2003 Oct 11
PMID 14535558
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy contends with endoscopic surgery for the role of treatment of choice for Tis-T1 glottic cancer. The amount of vocal cord to be surgically removed logically depends on the surface and deep extension of the neoplasm. Thus, a prerequisite for proper management includes an analysis of the voice changes after each of the progressive types of cordectomy described in the European Laryngological Society Classification. Between January 1998 and December 2000, 89 patients with glottic cancer (8 Tis, 63 T1a, 18 T1b) underwent different types of endoscopic cordectomy. Perceptual analysis (GRBAS scale); objective analyses of jitter, shimmer, and noise-to-harmonics ratio; and subjective (Voice Handicap Index) evaluation of voice were performed in 51 patients. Statistical evaluation of preoperative and postoperative objective results by analysis of covariance, as well as perceptual and subjective data, showed significant voice improvement after type I and II cordectomies, with the voice attaining nearly normal parameters. By contrast, after type III, IV, and V cordectomies, the vocal outcome was not significantly different from the preoperative pattern. It can therefore be concluded that type I and II resections, whenever indicated, are adequate procedures even for professional voice users. By contrast, accurate counseling is mandatory before type III, IV, and V cordectomies.

Citing Articles

Influence of age on voice quality after transoral CO laser microsurgery.

Lechien J, Hans S, Crevier-Buchman L J Otolaryngol Head Neck Surg. 2023; 52(1):59.

PMID: 37697412 PMC: 10496204. DOI: 10.1186/s40463-023-00664-3.


Voice quality after transoral CO laser microsurgery (TOLMS): systematic review of literature.

Colizza A, Ralli M, DElia C, Greco A, de Vincentiis M Eur Arch Otorhinolaryngol. 2022; 279(9):4247-4255.

PMID: 35505113 PMC: 9363323. DOI: 10.1007/s00405-022-07418-3.


T1a Glottic Cancer: Advances in Vocal Outcome Assessment after Transoral CO-Laser Microsurgery Using the VEM.

Song W, Caffier F, Nawka T, Ermakova T, Martin A, Murbe D J Clin Med. 2021; 10(6).

PMID: 33802971 PMC: 8002749. DOI: 10.3390/jcm10061250.


Quality of life and voice outcome of patients treated with transoral CO laser microsurgery for early glottic carcinoma (T1-T2): a 2-year follow-up study.

Hendriksma M, van Loon Y, Klop W, Hakkesteegt M, Heijnen B, El Hasnaoui I Eur Arch Otorhinolaryngol. 2019; 276(3):805-814.

PMID: 30810819 PMC: 6411677. DOI: 10.1007/s00405-019-05348-1.


Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.

van Loon Y, Hendriksma M, Heijnen B, van de Kamp V, Hakkesteegt M, Bohringer S Head Neck. 2019; 41(6):1638-1647.

PMID: 30652373 PMC: 6590407. DOI: 10.1002/hed.25582.